CAS: 2362-12-1; 4-Bromo-2-Methylphenol

该化合物是属于酚类的有机化合物,其特征是溴原子和附于苯球环的甲基组,具体地说,分别是松树和正角位置,该化合物一般是一种固体或晶体物质,具有独特的芳香味特征,在有机溶剂中可溶解,但由于苯球结构的疏水性,在水中溶解性有限. 4-Bromo-2-甲基酚的反微生物特性使其在各种应用中有用,包括作为防腐剂和其他化学化合物合成,其再活性受溴原子的存在影响,该物质可参与电子生物替代反应.在处理该化合物时,应当采取安全防范措施,因为如果摄入或吸入,可能会对健康造成危害,因此应当使用适当的保护设备来尽量减少接触.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号14804-31-0 4-溴-2-甲基苯甲醚 | CAS号95-48-7 邻甲酚 | CAS号583-75-5 4-溴-2-甲基苯胺 | CAS号2316-64-5 5-溴-2-羟基苯甲醇 | CAS号917-54-4 甲基锂 | CAS号118-79-6 三溴苯酚 | CAS号24106-05-6 4'-溴-2'-甲基乙酰苯胺 | CAS号56-23-5 四氯化碳 | CAS号3816-66-8 3-羟基-4-甲基苯腈 | CAS号32281-01-9 4-羟基-3-甲基苯硫酚 | CAS号452-72-2 4-氟-2-甲基苯酚 | CAS号4186-54-3 α,3,5-三溴-2-羟基甲苯 | CAS号20294-50-2 4-溴-2-甲基-6-硝基苯酚 | CAS号24224-30-4 3-甲基-9H-咔唑-2-醇 | CAS号30451-49-1 3-甲基-[1,1'-联苯]-4-醇 | CAS号2219-82-1 2-叔丁基-6-甲基苯酚 | CAS号338454-30-1 4-苄氧基-3-甲基苯硼酸 | CAS号95-71-6 鹿蹄草素

合成工艺路线路线简述

    邻甲酚置于n-溴代丁二酰亚胺(Nbs),2C5Hn10(3-)*2Mn(2+)*cu(2+)*5H2O体系中,用 乙腈 用作溶剂,化学反应 6.0H,以94%的收率获得4-溴-2-甲基苯酚
    参考文献:配位聚合物负载单点cu(II)催化剂的定向结构转变,以控制ch卤化位点的选择性
    标题:配位聚合物负载单点cu(II)催化剂的定向结构转变,以控制ch卤化位点的选择性
    摘要:C-h键功能化的主要困难是在发生反应的地方准确地控制催化剂.在这项工作中,为了获得高效和区域选择性的单中心催化剂,{[mn(hidbt)dmf].h 2 O} N(1)[h 3 Idbt = 5的三维(3D)菱形骨架构造了含有配位dmf分子的,5'-(1 H-咪唑-4,5-二基)-双(2 H-四唑)].对于溶解-再结晶的结构转变过程,有吸引力的结构转变从1到新的晶体形式为{[mn 3(idbt)2(h 2O)2 ].3H 2 O} N(2)具有3D窗口状结构,然后可以通过阳离子交换以单晶至单晶的方式将2中的mn离子与cu离子交换,从而生成cu-交换产物{[mn 2 Cu(idbt)2(h 2 O)2 ].3H 2 O} N(2A),其窗口状骨架类似于2.此外,2和2A用作非均相催化剂,用于苯酚与n的区域选择性c-h卤化-卤代琥珀酰亚胺(ncs和nbs)来生产定点选择性单卤代产物.发现2A的
    Doi:10.1021/acs.Inorgchem.9B01891

    海关参考信息

    专利信息


    专利号:US-8513465-B2
    优先权日:2008-02-04
    标题:Potassium organotrifluoroborate derivative and a production method therefor
    发明人:KANG HEONJOONG; HAM JUNGYEOB; AHN HONG RYUL; PARK YOUNG HEE
    权利人:KANG HEONJOONG; HAM JUNGYEOB; AHN HONG RYUL; PARK YOUNG HEE; SNU R&DB FOUNDATION
    摘要:Provided are a production method for a potassium organotrifluoroborate compound having a hydroxyl group, and a novel potassium organotrifluoroborate compound having a hydroxyl group. The production method is advantageous in that a potassium organotrifluoroborate compound can be produced in a single reaction without recourse to a process of isolating and purifying an intermediate. The novel potassium organotrifluoroborate compound having a hydroxyl group is useful as a reactant which is widely used in the total synthesis of physiologically active natural products and diverse organic synthesis reactions including halogen substitution reactions, 1,2- and 1,4-addition reactions using a rhodium (Rh) catalyst, and Suzuki coupling reactions using a palladium (Pd) catalyst.

    专利号:US-5116987-A
    优先权日:1988-12-26
    标题:Method of preparing chroman derivatives, and synthesis intermediates
    发明人:GARCIA GEORGES; METTEFEU DANIEL; ROUX RICHARD
    权利人:SANOFI SA
    摘要:The invention describes a method of synthesizing a compound of the formula ##STR1## in which X=O or NR, n Z=an electron-attracting group, n R=H, CN or NO 2 , n R 1 +R 2 +N--Câ•?X=a 5-membered or 6-membered heterocycle, and n R 3 =H, R 4 =OH or R 3 +R 4 =a bond, n said method involving intermediates of the formula ##STR2## in which R 5 =H, Br or N(R 1 )CXR 2 . This method of synthesis does not involve the epoxide derivative of the chroman. n The novel compounds of formula (IX) form a further subject of the invention.

    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:US-9505799-B2
    优先权日:2011-05-13
    标题:18F-labeled precursor of PET radioactive medical supplies, and preparation method thereof
    发明人:CHI DAE-YOON; LEE BYOUNG-SE; PARK CHANSOO; LEE MIN-HYUNG; CHA HYOJIN; CHO WOOJIN; KANG HEEWON; KIM KYUNGHUN
    权利人:CHI DAE-YOON; LEE BYOUNG-SE; PARK CHANSOO; LEE MIN-HYUNG; CHA HYOJIN; CHO WOOJIN; KANG HEEWON; KIM KYUNGHUN; FUTURECHEM CO LTD
    摘要:The present invention relates to a precursor of positron emission tomography (PET) radioactive medical supplies, a preparation method thereof, and an application thereof, and more specifically, to a precursor having a tetravalent organic salt leaving group, a preparation method, and a method for preparing desired PET radioactive medical supplies in a high radiochemical yield within a short preparation time by introducing 18 F using the same through a single step. The precursor having a tetravalent organic salt leaving group of the present invention can simplify the known complex multistep preparation of radioactive medical supplies into a single step, can save production costs because an excessive amount of a phase transfer catalyst is not required, facilitates separation of a compound after reaction, and enables rapid reaction velocity. The features are appropriate for the mass production of PET radioactive medical supplies by an automated synthesis system.

    专利号:US-9938258-B2
    优先权日:2012-11-29
    标 题:Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
    发明人:BALOGLU ERKAN; SHECHTER SHARON; SHACHAM SHARON; MCCAULEY DILARA; SENAPEDIS WILLIAM; GOLAN GALI; KALID ORI
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula I: n nor a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

    专利号:CN-113797212-B
    优先权日:2020-06-11
    标 题:Synthesis method and activity study of a group of antibacterial drugs containing mannose structure
    阜新锐晟科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rskjchem.com
    企业联系电话:0418-3904666 13841889768👤
    📞阜新锐晟科技有限公司 ⚠️参考联系方式
    联系人:韩经理
    电话:0418-3904666 13841889768
    手机:13841889768
    传真:0418-3904666
    邮箱:sales@rskjchem.com
    通信地址: 辽宁省阜新市太平区高德街道高孙路
    邮编: 123000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:辽宁省阜新市太平区高德街道高孙路
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    天津津御达化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinyudachem.com
    企业联系电话:022-23854368👤
    📞天津津御达化工科技有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:022-23854368
    手机:13011382049
    传真:022-23854368
    邮箱:sales@jinyudachem.com
    通信地址: 天津市华苑产业区华天道8号海泰信息广场C座209室
    邮编: 300400
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市华苑产业区华天道8号海泰信息广场C座209室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kwiecień, H., Science of Synthesis Knowledge Updates, (2014) 4, 176.
    摘要:González-Bello, C., Science of Synthesis Knowledge Updates, (2018) 1, 245.
    摘要:Pharmazie., 32(171), 1977 []
    摘要:Xiao, X., Science of Synthesis: Knowledge Updates, (2023) 2, 153.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知